ARWR
ARROWHEAD PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$58.98
+1.65%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 28.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 17.90x
- Price / sales
- 12.44x
- Price / cash flow
- -141.08x
Enterprise value
- Enterprise value
- $7.6B
- EV / sales
- 11.34x
- EV / EBITDA
- -56.81x
- EV / EBIT
- -33.54x
- Market cap
- $8.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026